Glaukos reported positive topline Phase 4 data for iDose TR used during cataract surgery in open-angle glaucoma and ocular ...

A soldier with gout, glaucoma, hypertension, and other illnesses was recognized fit for service by the Territorial ...

A large BJO study links statin use to lower open-angle glaucoma risk and fewer surgeries or eye drops. Learn the data, limits ...

The US-based eye-care company is also developing intraocular lens products, while low adoption of premium cataract procedures ...

Researchers evaluated whether retrieval augmentation improves the ability of large language models to answer perioperative ...

Investigators evaluated the efficacy of a sublingual sedative tablet for patients undergoing various oculoplastic surgical ...

SpyGlass Pharma, Inc. ( SGP) reported positive four-year results from its first-in-human study of the Bimatoprost Drug Pad-IOL System, an implant designed to provide long-term treatment for patients ...

SpyGlass Pharma reported 4-year glaucoma-lens data showing 37% eye pressure reduction in 21 patients, with 86% off daily ...

For 27 years, Abdullahi Abubakar lived in total darkness. Born in Kebbi State but raised in Wudil, Kano, he lost his sight at the age of three and grew up navigating life without vision. He has ...

Landmark European approval will grant young patients and families an evidence-based therapy alongside lifestyle interventionsAMSTERDAM, Oct.

SpyGlass Pharma has reported 4-year interim results from the first-in-human (FIH) trial of its Bimatoprost Drug Pad-IOL System (BIM-IOL System), extending what the company describes as the “longest ...

A review of 41 studies found that higher exposure to air pollution was linked to greater odds of glaucoma and cataracts.